InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the detailed record of transactions filed by Shlevin Harold H.. Director active across 1 company, notably Galectin Therapeutics INC. Cumulatively, 1 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €7k. Activity tracked since 30 December 2024. The latest transaction was disclosed on 30 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration